Outset Medical (OM) Raw Materials (2019 - 2026)

Outset Medical (OM) has reported Raw Materials for 8 consecutive years, with $30.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Raw Materials rose 14.37% year-over-year to $30.6 million in Q2 2026; TTM through Jun 2026 was $30.6 million, a 14.37% increase from a year earlier, with the FY2025 full-year figure at $27.2 million, up 5.76% from the prior year.
• Raw Materials was $30.6 million for Q2 2026 at Outset Medical, up from $29.9 million in the prior quarter.
• Over five years, Raw Materials peaked at $30.6 million in Q2 2026 and troughed at $16.0 million in Q1 2022.
• A 5-year average of $23.4 million and a median of $22.8 million in 2024 frame the typical range for Raw Materials.
• Across the five-year window, Raw Materials soared 54.15% in 2022 and declined 9.3% in 2023, its largest moves.
• Over 5 years, Raw Materials stood at $20.6 million in 2022, then retreated by 9.3% to $18.7 million in 2023, then jumped by 37.41% to $25.7 million in 2024, then advanced by 5.76% to $27.2 million in 2025, then grew by 12.71% to $30.6 million in 2026.
• The last three Raw Materials figures came in at $30.6 million (Q2 2026), $29.9 million (Q1 2026), and $27.2 million (Q4 2025), per Business Quant data.